Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
VERA

VERA - Vera Therapeutics, Inc. Stock Price, Fair Value and News

$45.08-1.67 (-3.57%)
Market Closed

Price Targets

VERA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VERA Price Action

Last 7 days

-1.5%

Last 30 days

-13.7%

Last 90 days

51.9%

Trailing 12 Months

18.9%

VERA RSI Chart

VERA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VERA Valuation

Market Cap

2.9B

Price/Earnings (Trailing)

-11.44

EV/EBITDA

-10.73

Price/Free Cashflow

-13.63

MarketCap/EBT

-10.13

VERA Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

VERA Fundamentals

VERA Earnings

Earnings (TTM)

-251.9M

Earnings Growth (Yr)

-72.18%

Earnings Growth (Qtr)

-4.92%

VERA Profitability

Return on Equity

-63.16%

Return on Assets

-48.68%

Free Cashflow Yield

-7.34%

VERA Investor Care

Shares Dilution (1Y)

0.96%

Diluted EPS (TTM)

-3.99

About Vera Therapeutics, Inc.

VERA
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
 CEO
 WEBSITEhttps://veratx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES49

Vera Therapeutics, Inc. Frequently Asked Questions

VERA is the stock ticker symbol of Vera Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Vera Therapeutics, Inc. is 2.88 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check VERA's fair value in chart for subscribers.

The fair value guage provides a quick view whether VERA is over valued or under valued. Whether Vera Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Vera Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VERA.